Hinge Health(HNGE.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Hinge Health
HNGE.US
Hinge Health, Inc. focuses on scaling and automating the delivery of healthcare services. The company leverages AI-powered care model, wearable devices, and access to clinicians to deliver evidence-based care services for musculoskeletal conditions. It primarily serves self-insured employers.
376.50 B
HNGE.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Analyst Expectations For Hinge Health's Future

    Analysts have evaluated Hinge Health (NYSE:HNGE) over the past three months, revealing a mix of bullish and bearish sentiments. The average 12-month price target is $64.11, down from $65.71. Recent actions include upgrades and downgrades from various analysts, reflecting market conditions. Hinge Health has shown a revenue growth rate of 53.27% but faces challenges with a net margin of -1.2% and low returns on equity and assets. The company's debt-to-equity ratio is favorable at 0.04, indicating a sound financial structure.

    benzinga_article·
    US
    XHS
    -0.71%
    US
    IHI
    -0.12%
    US
    HNGE
    -3.00%
    benzinga_article·
    US
    XHS
    -0.71%
    US
    IHI
    -0.12%
    US
    HNGE
    -3.00%

    Hinge Health, Inc. Class A (HNGE) Has a New Rating from Freedom Capital Markets

    Eugene Mannheimer from Freedom Capital Markets has initiated coverage of Hinge Health, Inc. Class A (HNGE) with a Buy rating and a price target of $59.00. Mannheimer is a 4-star analyst with a 6.3% average return and a 49.47% success rate. Additionally, Hinge Health received a Buy rating from TipRanks – Anthropic Medical, while TipRanks – DeepSeek maintained a Hold rating on the same day.

    Tip Ranks·
    US
    HNGE
    -3.00%
    Tip Ranks·
    US
    HNGE
    -3.00%

    Hinge Health Inc. to announce Q4 and full year 2025 financial results

    Hinge Health Inc. will announce its Q4 and full year 2025 financial results on February 10, 2026, after U.S. markets close. The results will be available on their Investor Relations website, and an earnings conference call will follow at 1:30 p.m. PT (4:30 p.m. ET) the same day, with a live audio webcast and replay accessible online.

    Reuters·
    US
    HNGE
    -3.00%
    Reuters·
    US
    HNGE
    -3.00%

    Hinge Health CEO Daniel Perez Reports Disposal of Common Shares

    Hinge Health CEO Daniel Perez has reported the disposal of common shares of Hinge Health Inc. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. Hinge Health Inc. published the original content via EDGAR on January 06, 2026, and is responsible for the information.

    Reuters·
    US
    HNGE
    -3.00%
    Reuters·
    US
    HNGE
    -3.00%

    Hinge Health Inc. (NYSE:HNGE) Short Interest Update

    Hinge Health Inc. (NYSE:HNGE) saw a 117.4% increase in short interest in December, totaling 4,180,660 shares. The days-to-cover ratio is 2.8 days. CEO Daniel Perez and CFO James Budge sold significant shares recently. Institutional investors adjusted their holdings, with some increasing stakes. Analysts have mixed ratings, with a consensus of "Moderate Buy" and a price target of $59.93. The stock opened at $47.57, with a 50-day average of $47.59 and a 200-day average of $49.34.

    Market Beat·
    US
    HNGE
    -3.00%
    Market Beat·
    US
    HNGE
    -3.00%
    © 2026 Longbridge｜Disclaimer